Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008, Article ID 834612, 18 pages
http://dx.doi.org/10.1155/2008/834612
Review Article

Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies

1Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
2Department of Environmental Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
3Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
4Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
5The Lymphoma Biology Program of James P. Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA
6The Lung Biology and Disease Program, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA

Received 17 March 2008; Accepted 21 April 2008

Academic Editor: Dipak Panigrahy

Copyright © 2008 Tatiana M. Garcia-Bates et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tatiana M. Garcia-Bates, Geniece M. Lehmann, Patricia J. Simpson-Haidaris, Steven H. Bernstein, Patricia J. Sime, and Richard P. Phipps, “Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies,” PPAR Research, vol. 2008, Article ID 834612, 18 pages, 2008. https://doi.org/10.1155/2008/834612.